Proposal No. 1: To approve the Company's issuance of Ordinary Shares, as described in the Proxy Statement, (a) to Oramed, as consideration for the acquisition of 100% of the outstanding shares of Ora…
Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP g…
Reciprocal relationship from ORMP graph: Reciprocal relationship from LFWD graph: Reciprocal relationship from ORMP graph: At the Notes Closing, Lifeward issued to the Company (i) $9,000,000.00 aggre…
the Company issued $10,000,000.00 aggregate principal amount senior secured convertible notes
Lifeward Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
LFWD-DEBT-10677
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2015-12-31.
LFWD-DEBT-10676
Warrants outstanding: 513930
90%
xbrl warrant detail from xbrl 2025-12-31.
LFWD-DEBT
Debt stack $8.8M
90%
Market cache reports total debt of $8.8M.
Lifeward Ltd. Acquisitions
Acquired Entity
Name
Confidence
Evidence
LFWD-ACQ-0001178913-26-000244
The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 1...
85%
The Company intends to issue ordinary shares to Oramed as consideration for the acquisition of 100% of the outstanding shares of Oratech.
LFWD-ACQ-0001178913-26-000642
Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from ...
85%
Lifeward Ltd. will issue ordinary shares as part of the consideration for acquiring assets from Skelable Ltd.
LFWD-ACQ-0001178913-26-001724
The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of ...
85%
The Company issued 1,296,296 warrants to purchase Ordinary Shares as part of the acquisition of Oratech Pharma.
LFWD-ACQ-0001178913-26-000875
Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for...
85%
Approval for the issuance of Ordinary Shares to Oramed Pharmaceuticals Inc. as consideration for the acquisition of 100% of the outstanding shares of Oratech Pharma, Inc.
Lifeward Ltd. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Lifeward Ltd..